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a b s t r a c t 
Human embryonic stem cells exhibit great potential as a 
therapeutic tool in regenerative medicine due to their self- 
renewal and trilineage differentiation capacity. Maintaining 
this unique cellular state has been shown to rely primar- 
ily on the Activin A / TGF β signaling pathway. While most 
conventional culture media are supplemented with TGF β , in 
the current study we utilize a modified version of the com- 
mercially available mTeSR1, substituting TGF β for Activin A 
in order to preserve pluripotency. (1) Cells cultured in ActA- 
mTesR express pluripotency factors NANOG, OCT4 and SOX2 
at comparable levels with cells cultured in TGF β-mTeSR. (2) 
ActA-mTeSR cultured cells retain a physiological karyotype. 
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(3) Cells in ActA-mTeSR maintain their trilineage differentia- 
tion capacity as shown in the teratoma formation assay. This 
system can be used to dissect the role of Activin A, down- 
stream effectors and signaling cascades in human embryonic 
stem cell responses. 
© 2021 The Authors. Published by Elsevier Inc. 
This is an open access article under the CC BY license 








i  pecifications Table 
Subject Cell Biology 
Specific subject area Human Embryonic Stem Cells 
Type of data Graph, Figure 
How data were acquired Image capture (Leica TCS SP8 and SP5 confocal microscopes, LASAF 
software) 
Western blotting (LI-COR Odyssey imaging system, image studio software) 
Data analysis (GraphPad Prism version 6.0) 
qRT-PCR (Light Cycler) 
Teratoma formation assay (H&E staining) 
Data format Raw, Analyzed 
Parameters for data 
collection 
H1 cells were cultured in TGF β or Activin A- based mTeSR1 for several 
passages were tested for expression of pluripotency markers, karyotypic 
abnormalities as well as for in vitro and in vivo differentiation capacity. 
Description of data 
collection 
Pluripotency assessment was performed by indirect immunofluorescence 
of H1 colonies with antibodies against NANOG, OCT4 and SOX2. In vitro 
differentiation potential was assessed by subjecting H1 cells to three 
separate protocols for mesoderm, endoderm and ectoderm differentiation. 
Karyotypic analysis was performed by colchicine-induced mitotic arrest 
and Giemsa staining. Assessing in vivo differentiation potential required 
the formation of teratomas in NOD/SCID mice and the subsequent H&E 
staining. 
Data source location University of Birmingham, School of Biosciences, Birmingham, United 
Kingdom 
Data accessibility Papadopoulos, Angelos (2021), “Supporting data on Combined 
transcriptomic and phosphoproteomic analysis of BMP4 signaling in 
human embryonic stem cells”, Mendeley Data, V1, 
https://doi.org/10.17632/tsk65tw2kx.1 
Related research article [1] A. Papadopoulos et al., “Combined transcriptomic and 
phosphoproteomic analysis of BMP4 signaling in human embryonic stem 
cells.,” Stem Cell Res. , vol. 50, no. November 2020, p. 102,133, Dec. 2020, 
https://doi.org/10.1016/j.scr.2020.102133 . 
alue of the Data 
• These data provide an Activin A dependent culture system substituting TGF β in mTeSR1 and
capable of maintaining the pluripotency of hESCs. 
• The culture system developed is a versatile tool for studying signaling pathways in hESCs. 
• This system allows for complete control over the growth factors and compounds included
in a standard hESC culture and can therefore be employed to develop novel pluripotency
maintenance or differentiation protocols. 
. Data Description 
To develop an mTeSR-dependent human embryonic stem cell (hESC) culture method replac-
ng TGF β with Activin A, H1 cells were cultured in mTeSR without select factors supplemented
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Fig. 1. H1 cells cultured in ActA-mTeSR express pluripotency markers and maintain a normal karyotype. (A) H1 cells 
cultured in ActA-mTeSR immunostained with α-NANOG, α-OCT4 and α-SOX2 antibodies. Scale bar = 10 μm. (B) H1 cells 
cultured in TGF β- (control) or ActA-mTeSR were lysed and immunoblotted with α-NANOG, α-OCT4 and α-TUBULIN 
antibodies. Expression levels of NANOG and OCT3/4 were quantified by densitometry using TUBULIN as loading control 
( N = 3). (C) H1 cells cultured in TGF β- (control) or ActA-mTeSR were arrested in metaphasis, lysed and the metaphasic 




















with LiCl, GABA, pipecolic acid and FGF2 at the concentrations stated in the manufacturer’s pro-
tocol [2] . Media was also supplemented with 0.6 ng/ml TGF β (TGF β-mTeSR) or 0.5 ng/ml Activin
A (ActA-mTeSR). After adapting cells in ActA-mTeSR for 10 passages, localization of the pluripo-
tency factors NANOG, OCT4 and SOX2 was assessed by immunofluorescence ( Fig. 1 A), protein
levels of NANOG and OCT4 were quantified by western blotting ( Fig. 1 B) and the karyotypic
profile was inspected by Giemsa staining ( Fig. 1 C). 
Subsequently, ActA-mTeSR-adapted cells were assessed for their in vitro trilineage differenti-
ation capacity. For mesodermal specification, H1 cells were induced with Activin A and BMP4.
BRACHYURY levels were analyzed by Western blotting ( Fig. 2 A). For ectodermal differentiation,
H1 cells were subjected to an embryoid body formation assay and stained for PAX6 ( Fig. 2 B). For
endodermal differentiation, H1 cells were induced with Activin A in a serum-containing medium
and transcription levels of SOX17 were evaluated by qPCR ( Fig. 2 C). 
Last, ActA-mTeSR cultured cells were assessed for their capacity to form in vivo teratomas.
Cells cultured in regular TGF β-mTeSR were used as a positive control. Teratoma size differences
between the two cell groups were not scored for, as this methodology was applied in a quali-
tative manner as a pluripotency test ( Fig. 2 D). Haematoxylin and eosin staining was applied to
visualize the different cell types that emerged ( Fig. 2 E). 
Activin A was first implicated in pluripotency when its precursor was found in the secretome
of mouse embryonic fibroblasts (MEFs) which served as feeders for hESC cultures [3] . Since then,
several Activin A-dependent systems have been developed for the undifferentiated propagation
of hESCs bypassing the need for MEFs or MEF secreted factors [ 4 , 5 ]. Our study provides an ad-
ditional versatile Activin A-dependent medium which allows for the study of pluripotency and
differentiation in a chemically defined background. 
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Fig. 2. H1 cells cultured in ActA-mTeSR retain their capacity for trilineage differentiation and in vivo teratoma formation. 
(A) H1 cells cultured in TGF β- (control) or ActA-mTeSR were differentiated towards mesoderm for 72 hrs, lysed and 
immunoblotted with α-BRACHYURY and α-ACTIN antibodies. (B) H1 cells cultured in TGF β- (control) or ActA-mTeSR 
were differentiated towards ectoderm following an embryoid body formation assay and immunostained with α-PAX6. (C) 
H1 cells cultured in TGF β- (control) or ActA-mTeSR were subjected to endodermal differentiation for 5 days. Total RNA 
was extracted and used to quantify SOX17 transcription levels by qPCR. (Di) Teratomas formed in 4 separate NOD/SCID 
mice by subcutaneous injections of H1 cells cultured in TGF β-mTeSR (left flank) or ActA-mTeSR (right flank). (Dii) TGF β- 
mTeSR (arrow) and ActA-mTeSR (arrowhead) cultured H1 cells were injected into the same animals to limit subject 
variability. (E) H&E-stained teratoma sections. Numbered arrows denote different cell types observed: (1) cartilage, (2) 













N  . Experimental Design, Materials and Methods 
.1. Cell culture conditions 
The matrigel-adapted hESC line H1 was purchased from WiCell (WB0113; Madison, WI, USA)
nd maintained in mTeSR without select factors (05,896; Stem Cell Technologies) supplemented
ith 1 mM lithium chloride (62,476; Sigma), 1 mM G-aminobutyric acid (A5835; Sigma), 0.1 mM
ipecolic acid (P2519; Sigma), 100 ng/mL FGF2 (11,343,627; ImmunoTools) and 0,5 ng/mL Activin
 (Dr Marko Hyvönen, University of Cambridge) or 0.6 ng/mL TGF β (100–21; Peprotech) on ma-
rigel (354,277; Corning) coated dishes. H1 cells were cultured at 37 °C in a humidified incubator
ontaining 5% CO 2 . 
.2. Immunofluorescence assays 
Sub-confluent H1 cells on 35 mm μ-dishes (IB81151; Ibidi) were subjected to immunoflu-
rescence as previously described [6] . Cells were incubated with primary antibodies against
ANOG (3580 s; Cell Signaling), OCT3/4 (sc-5279; Santa Cruz Biotechnology), SOX2 (MAB2018;

































R&D) and PAX6 (DHSB). Subsequently, samples were stained with Alexa Fluor ®488 α-Rabbit IgG
(711–545–152; Jackson ImmunoResearch), Alexa Fluor ®594 α-Mouse IgG (715–585–151; Jackson
ImmunoResearch) or FITC a-Mouse (715–095–151; Jackson ImmunoResearch) and DAPI (D9542;
Sigma). Samples were imaged using a Leica TCS SP8 or SP5 confocal microscope with a 40X/1.30
NA or 10X objective, and LASAF Imaging Software. All Images are maximum projections. 
2.3. Western blot analysis 
For western blotting, total cell lysates were electrophoresed and transferred onto nitrocel-
lulose membranes (10,600,012; GE Healthcare) which were incubated with primary antibodies
against NANOG, OCT3/4 and TUBULIN (E7; DSHB). Next, membranes were stained with near-
infrared fluorescent secondary antibodies IRDye ® 800CW α-Rabbit IgG (926–32,213; LI-COR)
and IRDye ® 680RD α-Mouse IgG (926–68,070; LI-COR). Results were visualized on a LI-COR
Odyssey imaging system. Densitometry was carried out using the Image Studio Lite software. For
Brachyury expression membranes were incubated with primary antibodies against BRACHYURY 
(R&D; AF2085) and ACTIN (EMD Millipore; MAB1501). For protein visualization, membranes
were incubated for 1 min with Amersham ECL Western Blotting Detection Reagent (Amersham;
RPN2209) and exposed onto Fuji Super Rx X-ray films. 
2.4. Quantitative real-time PCR 
Total RNA was extracted according to the manufacturer’s protocol (Macherey Nagel; 119–
22,402). Sample quantity and purity was determined using Nanodrop (ND-10 0 0 V3.8.1)
and samples were aliquoted and stored in −80 °C. qPCR reactions were prepared using
the QuantiTect SYBR ® Green RT-PCR Kit (Qiagen; 204,243) and appropriate primer pairs
to a final concentration of 3 μM. The reaction was performed in a Roche LightCycler
PCR System. CT values were normalized to GAPDH using the equation: 2 ̂ - Ct. Primer
sequences: SOX17 (FW:TCCCATGCACCCCCGACTC, RV:TGCTGGTGCTGGTGCTGGTGTTG), GAPDH 
(FW:CGCGCCCCCGGTTTCTAT, RV:CCTTCCCCATGGTGTCTGAGC). 
2.5. Differentiation protocols 
Mesoderm [7] : H1 cells were propagated for 72 hrs in 6 well plates. At that point, ActA-
mTeSR or TGF β-mTeSR was substituted with RPMI 1640 (Gibco; 21,875,034) containing 1%
Glutamax (Gibco; 35,050,061), 1% MEM Non-Essential Amino Acids (Gibco; 11,140,050), 1%
Penicillin-Streptomycin (Gibco; 15,070,063), 1% Insulin-Transferrin-Selenium (Gibco; 41,400,045), 
0.1 mM β-mercaptoethanol (Gibco; 31,350,010), 50 ng/ml Activin-A (Dr Marko Hyvönen, Univer-
sity of Cambridge) and 50 ng/ml BMP4 (Gibco; PHC9534). 
Endoderm [8] : H1 cells were propagated for 72 hrs in 6 well plates. At that point, ActA-mTeSR
or TGF β-mTeSR was substituted with RPMI 1640 (Gibco; 21,875,034) containing 1% Glutamax
(Gibco; 35,050,061), 1% Penicillin-Streptomycin (Gibco; 15,070,063), 0.5% Fetal Bovine Serum
(Gibco; 16,0 0 0,044) and 10 0 ng/ml Activin A (Dr Marko Hyvönen, University of Cambridge). At
24hr, medium was replenished and at 72hr FBS concentration was increased to 2%. Total RNA
was isolated 5 days after induction. 
Ectoderm [9] : H1 cells were seeded on non-adherent plates in DMEM/F-12 (Gibco;
12,634,010) containing 20% KnockOut Serum Replacement (Gibco; A3181502), 1% MEM Non-
Essential Amino Acids (Gibco; 11,140,050), 1% l -Glutamine (Gibco; 25,030,149) and 0.1 mM β-
mercaptoethanol (Gibco; 31,350,010). Suspension conditions enabled the folding of colonies
and the subsequent formation of embryoid bodies. At 96hr, cell aggregates were transferred
in DMEM/F-12 (Gibco; 12,634,010) containing 1% MEM Non-Essential Amino Acids (Gibco;




































B  1,140,050) and 2 μg/ml Heparin (Gibco; RP-43,138). After 7 days, embryoid bodies were trans-
erred to 35 mm μ-dishes (IB81151; Ibidi) that were pre-coated with laminin (Gibco; 23,017,015).
n day 10 cells were fixed with 4% PFA. 
.6. Karyotype 
Sub-confluent H1 cells cultured in ActA- or TGF β-mTeSR were treated with 0,04ug/ml Kary-
max colcemid (Gibco; 15,212) for 2 hrs at 37 °C. Next, cells were dissociated with trypsin,
pun down and resuspended in a hypotonic KCL solution (0,56% w/v) for 30 min at 37 °C.
ells were spun down, resuspended in 2 ml KCL and fixed by applying an ice-cold solution of
ethanol/acetic acid (3:1), dropwise. Fixed cells were kept at −20 °C overnight and processed
or Giemsa staining. 
.7. Teratoma formation assay 
Sub-confluent H1 cells cultured in ActA- or TGF β-mTeSR were manually dissected with an in-
ulin needle and digested with 1 mg/ml dispase (Gibco; 17,105–041). The cell clumps were spun
own for 3 min at 100 g and resuspended in 150 μl matrigel. The mixture was injected through
 25 G 7/8 needle (BD Biosciences; 305,124) subcutaneously into the hind legs of immunodefi-
ient NOD/SCID mice. Prior to injection, the matrigel, tips and syringes were stored on ice to
void matrix polymerization. Mice were maintained under pathogen free conditions, at the ani-
al house of the Biomedical Research Foundation (Academy of Athens, Greece). 10 weeks later,
nimals were sacrificed and the resulting teratomas were fixed, embedded in paraffin, dissected
nd stained with haematoxylin/eosin. 
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